Who owns MEI PHARMA INC?
- Ticker: LITS
- CUSIP Number: 55279b301
Tip: Access positions for across all investors
Analyze quarterly positions in Mei Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mei Pharma stock
Who bought or sold MEI PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 2.2M | $5.3M | 100% | Sep 2025 |
|
| Renaissance Technologies | 1.5M | $2.0M | 51% | Dec 2025 |
|
| Polar Securities | 1.2M | $2.8M | 100% | Sep 2025 |
|
| Vanguard Group | 1.1M | $1.5M | 54% | Dec 2025 |
|
| Marshall Wace | 759k | $1.0M | 955% | Dec 2025 |
|
| Mozayyx Management | 560k | $739k | 100% | Dec 2025 |
|
| Geode Capital Management | 331k | $438k | 41% | Dec 2025 |
|
| Quarry | 200k | $264k | -33% | Dec 2025 |
|
| Two Sigma Investments | 167k | $404k | 100% | Sep 2025 |
|
| BlackRock | 158k | $208k | 0% | Dec 2025 |
|
| Jane Street | 151k | $200k | -9% | Dec 2025 |
|
| UBS Group | 125k | $165k | -84% | Dec 2025 |
|
| State Street Corporation | 115k | $152k | 0% | Dec 2025 |
|
| XTX Topco | 111k | $147k | 62% | Dec 2025 |
|
| Susquehanna International | 94k | $125k | -62% | Dec 2025 |
|
| Quadrature Capital | 85k | $112k | 100% | Dec 2025 |
|
| Northern Trust | 80k | $106k | 19% | Dec 2025 |
|
| ADAR1 Capital Management | 67k | $89k | -77% | Dec 2025 |
|
| Alpine Partners VI | 50k | $66k | -1% | Dec 2025 |
|
| Hrt Financial | 32k | $42k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 27k | $65k | 0% | Sep 2025 |
|
| Group One Trading | 27k | $35k | -7% | Dec 2025 |
|
| Virtu Financial | 27k | $35k | 98% | Dec 2025 |
|
| Squarepoint Ops | 15k | $19k | 100% | Dec 2025 |
|
| Engineers Gate Manager | 14k | $18k | 100% | Dec 2025 |
|
| Two Sigma Securities | 12k | $16k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.2k | $4.3k | -86% | Dec 2025 |
|
| Newbridge Financial Services Group | 2.0k | $2.6k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 462.00 | $609.978600 | 0% | Dec 2025 |
|
| HighMark Wealth Management | 287.00 | $378.007700 | 0% | Dec 2025 |
|
| Evermay Wealth Management | 126.00 | $167.000400 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 75.00 | $99.000000 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 67.00 | $161.778200 | 100% | Sep 2025 |
|
| Wells Fargo & Company | 25.00 | $33.000000 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 2.00 | $2.000000 | 0% | Dec 2025 |
|
| CWM | 1.00 | $0 | 0% | Dec 2025 |
|
| International Assets Investment Management | 1.00 | $1.000000 | 100% | Dec 2025 |
|
| SBI Securities | 1.00 | $1.000000 | -89% | Dec 2025 |
|
Who sold out of Mei Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jain Global | Sep 2025 | 585k | $1.4M |
| Alyeska Investment Group | Sep 2025 | 495k | $1.2M |
| Vgi Partners Pty | Sep 2025 | 349k | $845k |
| NewGen Asset Management | Sep 2025 | 300k | $627k |
| Ghisallo Capital Management | Sep 2025 | 250k | $605k |
| Cantor Fitzgerald, L. P. | Sep 2025 | 240k | $581k |
| Meteora Capital | Sep 2025 | 125k | $302k |
| Boothbay Fund Management | Sep 2025 | 88k | $212k |
| Macquarie Group | Sep 2025 | 30k | $73k |
| Goldman Sachs Group | Sep 2025 | 30k | $72k |
| Thompson Davis & Co | Sep 2025 | 25k | $60k |
| Equitable Holdings | Sep 2025 | 10k | $24k |
| Simplex Trading | Sep 2025 | 8.2k | $19k |
| FMR | Jun 2025 | 5.00 | $12.000000 |